OsteoCentric Technologies has announced USD$30million in growth capital funding that it says will enable new product introductions which address implant instability as well as help it to expand applications of its UnifiMI technology.
The investment in OsteoCentric Technologies—founded in 2015 and based in Austin, USA—was led by Squadron Capital and OnPoint Advisors.
UnifiMI, which utilises a proprietary interlocking thread geometry, is designed to be a less invasive method in which to secure an implant to bone.
Eric Brown, founder and CEO of OsteoCentric Technologies, said: “Orthopaedic manufacturers have developed amazing implants over the years, but their methods for securing the implants to bone have remained largely unchanged for decades.
“Current methods can damage the bone, delay the patient’s return to motion, and are not designed to instantly interlock with the bone to optimise implant stability. OsteoCentric invented a less invasive method of securing implants to bone which is designed to preserve the bone and facilitate the patient’s return to motion.
“Our proprietary thread geometry is capable of instantly interlocking with the bone to optimise acute and long-term implant stability. Based on the widespread adoption of UnifiMI products by key opinion leader surgeons, mechanically integrated implants are rapidly setting a new performance standard for instantly securing implants to normal and compromised bone.”